Benzinga | Nov 2, 2021 05:43PM EDT

Aquestive Therapeutics Q3 EPS $(0.37) Beats $(0.45) Estimate, Sales $13.29M Beat $11.01M Estimate

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.45) by 17.78 percent. This is a 24.49 percent increase over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $13.29 million which beat the analyst consensus estimate of $11.01 million by 20.68 percent. This is a 60.86 percent increase over sales of $8.26 million the same period last year.